The value of a new marker, des-γ-carboxyprothrombin (DCP) in the diagnosis of primary hepatocellular carcinoma (PHC)
✍ Scribed by Kavallierou, L.; Tsiodra, P.; Efstratopoulos, A.; Meikopoulos, M.; Pittaros, Ch.; Antipas, A.; Renieri, N.
- Book ID
- 123211981
- Publisher
- Elsevier Science
- Year
- 1990
- Tongue
- English
- Weight
- 110 KB
- Volume
- 11
- Category
- Article
- ISSN
- 0168-8278
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## DING-SHINN CHEN To evaluate the role of plasma des-y-carboxyprothrombin in the early diagnosis of hepatocellular carcinoma, we simultaneously studied both des-y-carboxyprothrombin activities by staphylocoagulase method and des-y-carboxyprothrombin antigen levels by enzyme immunoassay in 39 pati
Serum alpha-fetoprotein (AFP) has been measured during chemotherapy of ten patients with hepatocellular carcinoma. Whenever the AFP concentration of a sample was lower than that of the previous sample the apparent half-life (AHL) of the protein was calculated. The biological half-life of AFP is 5 da